The recombinant human thyroid stimulating hormone (rhTSH) containing oligosaccharides terminated with NeuAc(a2-3)Gal(q1-4)GlcNAc(31 showed higher in vivo activity and lower metabolic clearance rate (MCR) SO44GalNAc(031-4)GlcNAcI31 but also with NeuAc(a2-3 or a2-6)Gal(j31-4)GlcNAcl31 (6, 7). Recombinant human TSH (rhTSH) expressed in Chinese hamster ovary (CHO) cells differs from the phTSH in its glycosylation pattern; the N-linked glycans on the rhTSH contain only NeuAc(a2-3)Gal(f31-4)GlcNAcf31-terminal sequence (8, 9) . We have shown that rhTSH with highly sialylated oligosaccharide chains had longer plasma half-life and higher in vivo bioactivity despite lower in vitro bioactivity compared to the predominantly sulfated phTSH or enzymatically desialylated rhTSH (asialo-rhTSH; asrhTSH) (3).
indicating that sialylation of a but not ( subunit attenuates the intrinsic activity of TSH. In contrast, hybrids with (3 subunit from rhTSH displayed lower MCR compared to those with (3 subunit from phTSH. The phTSHa-rhTSH(8 hybrid had the highest in vivo bioactivity followed by rhTSHa-rhTSH.3, rhTSHa-phTSHI3, phTSHa-phTSH(3, and asrhTSH dimers.
These differences indicated that hybrids with (3 subunit from rhTSH displayed the highest in vivo activity and relatively low MCR, probably due to higher sialylation, more multiantennary structure, and/or the unique location of the (8-subunit oligosaccharide chain in the molecule. Thus, the N-linked oligosaccharides of the (3 subunit of glycoprotein hormones have a more pronounced role than those from the a subunit in the metabolic clearance and thereby in the in vivo bioactivity. In contrast, the terminal residues of a-subunit oligosaccharides have a major impact on TSH intrinsic potency.
The thyroid-stimulating hormone thyrotropin (TSH) is a pituitary heterodimeric glycoprotein composed of two noncovalently linked subunits: an a subunit common with the gonadotropins and a hormone-specific ,3 subunit. The a subunit contains two N-linked oligosaccharide chains and the ,B subunit contains one (1) . TSH, like most glycoproteins, is produced and secreted not as a single structure but as a mixture of glycosylation isoforms with different bioactivity (2) (3) (4) (5) . Pituitary human TSH (phTSH) oligosaccharides are complextype structures and terminate predominantly with SO44GalNAc(031-4)GlcNAcI31 but also with NeuAc(a2-3 or a2-6)Gal(j31-4)GlcNAcl31 (6, 7) . Recombinant human TSH (rhTSH) expressed in Chinese hamster ovary (CHO) cells differs from the phTSH in its glycosylation pattern; the N-linked glycans on the rhTSH contain only NeuAc(a2-3)Gal(f31-4)GlcNAcf31-terminal sequence (8, 9) . We have shown that rhTSH with highly sialylated oligosaccharide chains had longer plasma half-life and higher in vivo bioactivity despite lower in vitro bioactivity compared to the predominantly sulfated phTSH or enzymatically desialylated rhTSH (asialo-rhTSH; asrhTSH) (3) .
Previous studies investigating the role of oligosaccharides on individual subunits in biological function of glycoprotein hormones have used two major approaches. First, dimerization of chemically or enzymatically deglycosylated subunits has been used (10) (11) (12) . Second, in vitro mutagenesis of the glycosylation sites of different gonadotropins has been used to elucidate the role of each individual oligosaccharide chain (13) (14) (15) . However, these strategies permit elucidation of differences related only to the presence or absence of an entire carbohydrate chain in a specific subunit or glycosylation site. Moreover, it is known, for example, that desialylation may have a more pronounced effect on the metabolic clearance rate (MCR) and in vivo bioactivity than deglycosylation (16) . Thus, oligosaccharide removal by deglycosylation or mutagenesis was not adequate to determine biological function of a particular oligosaccharide structure on each subunit. Furthermore, previous studies in this field have not used dimerization of TSH subunits with defined carbohydrate composition to address this question.
We have exploited the availability of exclusively sialylated rhTSH preparations expressed in CHO cells as well as highly purified phTSH with known oligosaccharide structures to assess the contribution of sialylation and sulfation in each of the subunits in biological properties of TSH. Present studies of phTSH and rhTSH subunit hybrids indicated that the N-linked carbohydrate residues of the 3 subunit play a more important role than those of the a subunit in determining MCR, which has a major impact on in vivo bioactivity. Moreover, our data demonstrate that terminal sialic acid residues on the a but not on the 13 subunit attenuate hTSH intrinsic potency, further emphasizing a distinct role of terminal sialylation in each subunit.
MATERIALS AND METHODS
Materials. hTSH (AFP-8600B) was obtained from the National Hormone and Pituitary Program (Baltimore). rhTSH was produced by Genzyme as described (8, 17 10 Center Drive, Bethesda, MD 20892.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. gradient (40-70%) of acetonitrile in 0.1 M triethylamine phosphate buffer (pH 6.5) at a flow rate of 1.6 ml/min. Fractions containing subunits were collected and desalted by gel filtration on a Superdex 75 HR 30/10 column (Pharmacia). The column was eluted with 0.5% ammonium bicarbonate, which was later removed by lyophilization. Purity of rhTSH, asrhTSH, and phTSH subunits was verified by SDS/PAGE as described (3).
Preparation of Desialylated rhTSH. Neuraminidase digestion and sialic acid release were performed and monitored as described (8) .
Carbohydrate Analyses. The a and 3 subunits of TSH were hydrolyzed with 2.75 M trifluoroacetic acid (Sequanal grade, Pierce) for 4 h at 100°C and analyzed for carbohydrate composition by high-pH anion-exchange chromatography with a pulsed amperometric detector on a Dionex BioLC system using an AS6 lonopak column (Dionex) as described (8) . Samples for sialic acid compositional analysis were hydrolyzed with 0.2 M HCl and analyzed on the same column as described (3) . For sulfate composition, samples were hydrolyzed with 0.25 M HCI at 100°C for 4 h. The hydrolysate was dried and reconstituted in deionized water, and the sulfate content was analyzed using an AS5 anion-exchange column and a conductivity detector (Dionex).
Preparation of hTSH Hybrids. phTSH, rhTSH, and asrh-TSH subunits were mixed at a concentration of 1 mg/ml or more in 50 mM Tris HCl (pH 7.4) and recombined overnight at 37°C. The efficiency of combination was "60% as estimated by TSH and protein assays; the uncombined subunits were separated from TSH dimers using a gel filtration column (Superdex 75 HR 30/10; Pharmacia). Hybrids used in functional studies are shown in Fig. 1 . The amount of hybrids was quantitated by two different immunoassays: (i) LumaTag hTSH assay (Nichols Institute, San Juan Capistrano, CA) and (ii) Coat-A-Count TSH IRMA (Diagnostic Products, Los Angeles). These immunoassays use monoclonal antibodies that have no cross-reactivity with the individual subunits, do not recognize mouse or rat TSH, show no cross-reactivity with other glycoprotein hormones, and are not sensitive to changes in carbohydrate structure (3, 8, 12, 16) .
In Vitro Bioassays. The receptor binding activities of the various rhTSH and hTSH hybrids were assayed as described (3, 8) using 1251-labeled bovine TSH and soluble porcine thyroid membranes (Kronus, Dana Point, CA). The CHO cells with stably expressed hTSH receptor (CHO-JP09) provided by G. Vassart (University of Brussels) were grown in 96-well plates (Costar) in Ham's F-12 medium (ABI, Columbia, MD) containing 5% fetal bovine serum (Applied Biosystems), glutamine (2 mM), penicillin (100 units/ml), and streptomycin (100 ,ug/ml). The cells were washed and incubated with KRB buffer (pH 7.4) containing 4 mM isobutylmethylxanthine (Sigma), 1 mg of bovine serum albumin per ml, and different concentrations of the TSH hybrids for 120 min at 37°C. The FRTL-5 cells (subclone BL) provided by L. D. Kohn (Interthyr Research Foundation, Baltimore) were grown and incubated with different concentrations of TSH as described (3) . cAMP content in the aspirated media from both cell line assays was measured by radioimmunoassay with a specific antibody (8) . A curve-fitting program, MACALLFIT (version 1.04) was used to fit the dose-response data and to calculate EC50 values.
Metabolic Clearance Studies. Young male Sprague-Dawley rats (150-200 g; strain Crl:CD BR; Charles River Breeding Laboratories) were anesthetized with sodium pentobarbital (Somnifer, Richmond Veterinary Supply, Richmond, VA; 2 g per kg of body weight, i.p.). The left femoral vein of the rats was catheterized using a Jelco i.v. catheter (24G, 19 mm, Critikon, Tampa, FL) after vein exposure in the region of the groin. The in vivo clearance of various TSH preparations was determined by injecting 0.5-1.0 j,g of the sample i.v. and then measuring serum TSH concentrations at several time points from 1 to 120 min as described (3) .
In Vivo Bioassay. Modification of the McKenzie TSH assay was used to determine biopotency of TSH samples in vivo (3, 18) . Male albino Swiss CF-1 mice were given triiodothyronine in their drinking water for 5-6 days to suppress endogenous TSH. Different doses of hTSH hybrids were injected i.p. and blood samples were obtained from the orbital sinus 6 h later. Total thyroxine in serum was measured by radioimmunoassay (Incstar, Stillwater, MN).
RESULTS
Carbohydrate Analyses. Monosaccharide compositional analysis of TSH using high-pH anion-exchange chromatography with a pulsed amperometric system showed that rhTSH has an average composition of 1.9 sialic acid residues per chain, compared to phTSH which has only 0.4-0.5 residue per chain. N-Acetylgalactosamine and sulfate are absent in rhTSH, in contrast to phTSH. Moreover, further analysis indicated that rhTSH contained more di-, tri-, and tetrasialylated carbohydrate chains than the phTSH preparation (9) . The amounts of monosaccharides in different TSH subunits and their molar ratios normalized to mannose = 3 are shown in Table 1 . Neither GalNAc nor sulfate was detected in both rhTSH subunits, whereas significant amounts were found in the phTSH subunits. The absence of GalNAc in rhTSH subunits is consistent with the absence of terminal sulfate moieties that are normally present in cadaver-derived phTSH. Interestingly, sialic acid content of rhTSH was slightly higher in the 3subunit (2.3 residues per chain) than in the a subunit (1.7 residues per chain), reflecting the presence of more multiantennary-type structures (unpublished observation).
Terminal Residues of the a-Subunit Oligosaccharides Regulate Hormone Intrinsic Activity. TSH hybrids were examined by using various in vitro bioassays, including stimulation of cAMP in CHO-JP09 cells. As shown in Fig. 2A, dimers rhoarho J rrh-ahrhp| Jasrhorho   FIG. 1 . Preparation of hTSH subunit hybrids. rhTSH, asrhTSH, and phTSH subunits were dissociated and then reassociated in various combinations shown to obtain differentially glycosylated preparations. Hybrids recombined from the subunits of the same preparation served as controls. All these derivatives were further studied in vitro and in vivo in order to relate their carbohydrate structure to biological function. hybrids containing the same a subunit but a different 1 subunit showed similar bioactivity. The control preparation of rhTSH showed activity similar to hybrids containing recombinant a subunit. The data show that the displacement curves for the rhTSH and phTSH hybrids were parallel and that the concentrations required for 50% displacement of the label were similar to control.
Similar to the role of a-subunit carbohydrates in in vitro activity of pituitary recombinant hybrids, recombinant-asialorecombinant TSH dimers (Fig. 2B) containing desialylated a subunit were more active in vitro, requiring 3-to 5-fold lower concentrations for half-maximal response than the derivatives containing fully sialylated recombinant a subunit. (EC5o values in ng/ml were as follows: asrha-asrh3, 1.15 ± 0.25; asrha-rh1, 1 .85 ± 0.20; rha-asrh3, 5 .77 + 0.36; rha-rh13, 6 .23 ± 0.21.) Differences in bioactivity of hybrids correlate with differences in sialylation and sulfation shown earlier (Table 1) . Hybrids with identical a subunit but different, desialylated or fully sialylated 13 subunit showed similar bioactivity. This clearly indicated that sialic acid removal from only a and not 1 subunit is necessary to increase in vitro activity of highly sialylated rhTSH. We have obtained essentially similar results with CHO-JP09 cells (Fig. 2) as well as with FRTL-5 cells (data not shown).
Terminal Residues on a-Subunit Oligosaccharides Regulate TSH Clearance from the Circulation. Since it is known that both sialylation and sulfation influence the MCR of glycoproteins, we examined the clearance rates of TSH hybrids in rats. Serum disappearance curves are shown in Fig. 3 . MCR values calculated in ml/min were as follows: rha-rh1, 1 .0 + 0.3; pha-rh13, 1.2 + 0.2; rha-ph13, 1.7 ± 0.1; pha-ph1, 4.2 + 0.5; asrha-asrh13, 6.2 ± 0.5. As observed previously for the native preparation, the pha-ph13 hybrid is cleared significantly faster than hybrids containing one or both rhTSH subunits (Fig. 3A) . Interestingly, the pha-rh13 hybrid showed a MCR comparable to the control rha-rh13 hybrid but clearly lower than the rha-ph13 hybrid. This indicates that the single oligosaccharide chain of the 13 subunit is critical for clearance of sulfated and sialylated TSH hybrids. Serum disappearance curves of injected rhTSH-asrhTSH hybrids are shown in Fig.  3B . It is apparent that asrhTSH hybrids with sialic acid removed from either subunit were cleared significantly faster than rha-rh13 with sialic acid intact in both subunits ( Table 1) . As shown, in most cases the MCR is inversely related to the degree of sialylation of the given hybrid. However, the MCR of rhTSH hybrids desialylated in either subunit (asialo-rharh13 and rha-asialo-rh,B) is similar and almost as high as the MCR of rhTSH desialylated in both subunits. The control rha-rh13 hybrid is cleared much slower than MCR, similar to the initial rhTSH preparation (3).
In Vivo Bioactivity. To determine in vivo activity of the hybrids, we have used a modification of the McKenzie bioassay (3, 18 ). Stimulation of the thyroxine level in serum by different rhTSH, asrhTSH, and phTSH hybrids is shown in Fig. 4 . Hybrids with recombinant 1 subunit were 2-to 3-fold more active than those with pituitary 13 subunit, despite even lower in vitro bioactivity. The amounts of TSH injected required for half-maximal response were as follows: pha-rh13, 0.18 ± 0.04 ,g; rha-rhB, 0.29 ± 0.05 ,ug; rha-ph13, 0.42 ± 0.04 ,ug; pha-ph13, 0.80 ± 0.07 ,ug. The pha-rh,B hybrid was significantly more active than the rha-rh,B control dimer, reflecting differences observed in vitro. In contrast, the asrhTSH hybrid has the lowest in vivo potency of all hybrids despite its high intrinsic activity (Fig. 2B) . The asrhTSH hybrids showed a major decrease in bioactivity comparable to that of completely desialylated rhTSH.
DISCUSSION
Terminal sialic acid residues present on the TSH a subunit negatively modulate the in vitro activity of the hormone, whereas those on the 13 subunit do not contribute to that activity. In contrast, the oligosaccharide structures of the TSH (3 subunit are more important than that of the a subunit in the metabolic clearance of hTSH. The differential role of the specific sialylated and sulfated carbohydrate structure of TSH subunits in regulation of metabolic clearance and thereby in in vivo bioactivity has not been previously reported. Many earlier studies on the role of oligosaccharide chains in the bioactivity of glycoprotein hormones employed solely in vitro bioassays, which are not sensitive to the effect of glycosylation on the in vivo clearance mechanisms, which are, in fact, highly affected by terminal carbohydrate moieties (2, 5) . Moreover, studies involving chemically or enzymatically deglycosylated TSH may underestimate or overestimate the role of subunit ;glycosylation. Furthermore, the effects of glycosylation site elimination by site-directed mutagenesis may be secondary to amino acid change or may change oligosaccharide processitg in the remaining glycosylation sites versus the fully glycosylated control.
Dimerization of deglycosylated glycoprotein hormones as well as specific removal of carbohydrate chains by site-directed mutagenesis indicated that the carbohydrate chains of the a subunit, particularly that at position 52, are of primary importance in signal transduction (10, (12) (13) (14) (15) (12) (13) (14) (15) .
Based on the assumption of similar general structure of hTSH and hCG, the importance of a-subunit carbohydrates in TSH intrinsic activity can be interpreted by using the threedimensional model of CG derived from recent studies of hCG (19, 20) . The carbohydrate chain at Asn52 of hCG reported as critical for signal transduction is positioned at the dimer interface. Sialic acid in this position may directly contribute to the receptor binding site and be repelled by negatively charged receptor residues. This mechanism may explain why desialylation as well as removal of the carbohydrate chain increase receptor binding.
Although many studies addressing the role of carbohydrate residues in glycoprotein hotmones have been performed on gonadotropins, which are structurally similar to TSH, it is now becoming increasingly apparent that the effect of glycosylation on both in vitro and in vivo bioactivity cannot be generalized but rather must be determined for each specific glycoprotein (21, 22) . For example, terminal sialic acid residues may affect bioactivity of closely related glycoprotein hormones in different ways, related to both species-and hormone-specific receptor interactions (23) (24) (25) (26) (27) . As reported, highly sialylated (3-subunit carbaoydrate chains of hCG are important in prolonging plasma' half-life (10, 23) . Moreover, deglycosylation of the hCG a subunit resulted in a dimer that had a plasma half-life similar to that of the fully glycosylated hCG, whereas deglycosylation of the hCG (3 subunit decreased plasma halflife of the dimer (10 of the phTSH a subunit by a specific liver receptor. This hypothesis is supported in part by the observation that gonadotropin f3 subunit can influence oligosaccharide processing of noncovalently bound a subunit (28) . Our findings suggest that sialylated and sulfated oligosaccharide structures of TSH, each to a different extent and in a site-and subunit-specific manner, determine glycoprotein hormone distribution as well as plasma levels and thereby in vivo potency. Desialylation of either subunit significantly decreased serum half-life, indicating that the asialoglycoprotein receptor in liver hepatocytes recognizes Gal-terminated residues in either subunit. However, the affinity of phTSH-rhTSH hybrids to GalNAc sulfate-specific receptors in the liver may reflect not only the number of sulfated GalNAc residues in their N-linked oligosaccharides but also local protein-carbohydrate and/or carbohydratecarbohydrate interactions in the TSH molecule. Desialylation of rhTSH a subunit resulted in higher in vitro, but lower in vivo, bioactivity than normal rhTSH. In contrast, desialylation of the 3 subunit resulted in no change of in vitro, but lower in vivo, bioactivity. Highly sialylated rhTSH escapes from asialoglycoprotein receptor-mediated clearance in the liver, whereas the glycoprotein hormones with sulfated oligosaccharide structures are cleared in the liver by a sulfate-specific receptor but much less efficiently than desialylated hormones (29) (30) (31) .
Analysis of individual N-linked oligosaccharide residues of hCG and hTSH subunits revealed that different ratios of carbohydrate structures are present at each site (7, 24) . The physiological role of terminal carbohydrate residues may be different at different glycosylation sites but also may depend on the presence of a particular carbohydrate structure. Currently, rhTSH is being clinically tested as a diagnostic agent in patients with thyroid carcinoma and recently it has been demonstrated that the use of rhTSH in humans is an effective method to stimulate 131I uptake without the disadvantages of hypothyroidism (32) . Our data may permit design of rhTSH analogs with the a subunit expressed in a cell line with the ability to sulfate and the ,B subunit produced in one that sialylates, such as CHO cells. In addition to their therapeutic potential glycoprotein hormone subunit hybrids with different carbohydrate structures or without carbohydrates, such as hCG (3 subunit expressed in Escherichia coli (33) , can be helpful in extending and verifying the data on elimination of specific glycosylation sites by site-directed mutagenesis.
